Skip to main content

03.04.2019 | Topic Paper

Metagenomics in diagnosis and improved targeted treatment of UTI

verfasst von: Matthew Dixon, Maria Stefil, Michael McDonald, Truls Erik Bjerklund-Johansen, Kurt Naber, Florian Wagenlehner, Vladimir Mouraviev

Erschienen in: World Journal of Urology

Einloggen, um Zugang zu erhalten

Abstract

Introduction

The genomic revolution has transformed our understanding of urinary tract infection. There has been a paradigm shift from the dogmatic statement that urine is sterile in healthy people, as we are becoming forever more familiar with the knowledge that bacterial communities exist within the urinary tracts of healthy people. Metagenomics can investigate the broad populations of microbial communities, analysing all the DNA present within a sample, providing comprehensive data regarding the state of the microenvironment of a patient’s urinary tract. This permits medical practitioners to more accurately target organisms that may be responsible for disease—a form of ‘precision medicine’.

Methods and Results

This paper is derived from an extensive review and analysis of the available literature on the topic of metagenomic sequencing in urological science, using the PubMed search engine. The search yielded a total of 406 results, and manual selection of appropriate papers was subsequently performed. Only one randomised clinical trial comparing metagenomic sequencing to standard culture and sensitivity in the arena of urinary tract infection was found.

Conclusion

Out of this process, this paper explores the limitations of traditional methods of culture and sensitivity and delves into the recent studies involving new high-throughput genomic technologies in urological basic and clinical research, demonstrating the advances made in the urinary microbiome in its entire spectrum of pathogens and the first attempts of clinical implementation in several areas of urology. Finally, this paper discusses the challenges that must be overcome for such technology to become widely used in clinical practice.
Literatur
1.
Zurück zum Zitat Mouraviev V, McDonald MW (2018) An implementation of next generation sequencing for prevention and diagnosis of urinary tract infection in urology. Can J Urol 25:9349–9356PubMed Mouraviev V, McDonald MW (2018) An implementation of next generation sequencing for prevention and diagnosis of urinary tract infection in urology. Can J Urol 25:9349–9356PubMed
2.
Zurück zum Zitat Forbes JD, Knox NC, Ronholm J et al (2017) Metagenomics: the next culture-independent game changer. Front Microbiol 8:1069CrossRef Forbes JD, Knox NC, Ronholm J et al (2017) Metagenomics: the next culture-independent game changer. Front Microbiol 8:1069CrossRef
4.
Zurück zum Zitat Knief C (2014) Analysis of plant microbe interactions in the era of next generation sequencing technologies. Front Plant Sci 5:206CrossRef Knief C (2014) Analysis of plant microbe interactions in the era of next generation sequencing technologies. Front Plant Sci 5:206CrossRef
5.
Zurück zum Zitat Rizzo JM, Buck MJ (2012) Key principles and clinical applications of “Next-Generation” DNA sequencing. Cancer Prev Res 5:887–900CrossRef Rizzo JM, Buck MJ (2012) Key principles and clinical applications of “Next-Generation” DNA sequencing. Cancer Prev Res 5:887–900CrossRef
6.
Zurück zum Zitat Wellinghausen N, Kochem AJ, Disqué C et al (2009) Diagnosis of bacteremia in whole-blood samples by use of a commercial universal 16S rRNA gene-based PCR and sequence analysis. J Clin Microbiol 47:2759–2765CrossRef Wellinghausen N, Kochem AJ, Disqué C et al (2009) Diagnosis of bacteremia in whole-blood samples by use of a commercial universal 16S rRNA gene-based PCR and sequence analysis. J Clin Microbiol 47:2759–2765CrossRef
7.
Zurück zum Zitat Prachayangprecha S, Schapendonk CM, Koopmans MP et al (2014) Exploring the potential of next-generation sequencing in detection of respiratory viruses. J Clin Microbiol 52:3722–3730CrossRef Prachayangprecha S, Schapendonk CM, Koopmans MP et al (2014) Exploring the potential of next-generation sequencing in detection of respiratory viruses. J Clin Microbiol 52:3722–3730CrossRef
8.
Zurück zum Zitat McDonald MW, Kameh D, Johnson ME et al (2017) A head-to-head comparative phase ii study of standard urine culture and sensitivity versus DNA next-generation sequencing testing for urinary tract infections. Rev Urol 19:213–220PubMedPubMedCentral McDonald MW, Kameh D, Johnson ME et al (2017) A head-to-head comparative phase ii study of standard urine culture and sensitivity versus DNA next-generation sequencing testing for urinary tract infections. Rev Urol 19:213–220PubMedPubMedCentral
9.
Zurück zum Zitat Wagenlehner FM, Abramov-Sommariva D, Höller M et al (2018) Non-Antibiotic Herbal Therapy (BNO 1045) versus antibiotic therapy (fosfomycin trometamol) for the treatment of acute lower uncomplicated urinary tract infections in women: a double-blind, parallel-group, randomized, multicentre, non-inferiority phase III trial. Urol Int 101:327–336CrossRef Wagenlehner FM, Abramov-Sommariva D, Höller M et al (2018) Non-Antibiotic Herbal Therapy (BNO 1045) versus antibiotic therapy (fosfomycin trometamol) for the treatment of acute lower uncomplicated urinary tract infections in women: a double-blind, parallel-group, randomized, multicentre, non-inferiority phase III trial. Urol Int 101:327–336CrossRef
10.
Zurück zum Zitat Elshal AM, Atwa AM, El-Nahas AR et al (2018) Chemoprophylaxis during transrectal prostate needle biopsy: critical analysis through randomized clinical trial. World J Urol 36:1845–1852CrossRef Elshal AM, Atwa AM, El-Nahas AR et al (2018) Chemoprophylaxis during transrectal prostate needle biopsy: critical analysis through randomized clinical trial. World J Urol 36:1845–1852CrossRef
11.
Zurück zum Zitat Mouraviev V, McDonald MW, Skinner C et al (2018) MP15-14 the value of next generation dna sequencing testing in rectal swabs before transrectal prostate biopsy for individual and targeted prophylaxis of urinary tract infection. J Urol 199(4):e194 Mouraviev V, McDonald MW, Skinner C et al (2018) MP15-14 the value of next generation dna sequencing testing in rectal swabs before transrectal prostate biopsy for individual and targeted prophylaxis of urinary tract infection. J Urol 199(4):e194
12.
Zurück zum Zitat Sfanos KS, Isaacs WB, De Marzo AM (2013) Infections and inflammation in prostate cancer. Am J Clin Exp Urol 1:3–11PubMedPubMedCentral Sfanos KS, Isaacs WB, De Marzo AM (2013) Infections and inflammation in prostate cancer. Am J Clin Exp Urol 1:3–11PubMedPubMedCentral
13.
Zurück zum Zitat Shrestha E, White JR, Yu SH et al (2017) Profiling the urinary microbiome in men with positive versus negative biopsies for prostate cancer. J Urol 199:161–171CrossRef Shrestha E, White JR, Yu SH et al (2017) Profiling the urinary microbiome in men with positive versus negative biopsies for prostate cancer. J Urol 199:161–171CrossRef
14.
Zurück zum Zitat Frugé AD, Ptacek T, Tsuruta Y et al (2018) Dietary changes impact the gut microbe composition in overweight and obese men with prostate cancer undergoing radical prostatectomy. J Acad Nutr Diet 118:714–714.e1CrossRef Frugé AD, Ptacek T, Tsuruta Y et al (2018) Dietary changes impact the gut microbe composition in overweight and obese men with prostate cancer undergoing radical prostatectomy. J Acad Nutr Diet 118:714–714.e1CrossRef
15.
Zurück zum Zitat Cavarretta I, Ferrarese R, Cazzaniga W et al (2017) The microbiome of the prostate tumor microenvironment. Eur Urol 72:625–631CrossRef Cavarretta I, Ferrarese R, Cazzaniga W et al (2017) The microbiome of the prostate tumor microenvironment. Eur Urol 72:625–631CrossRef
16.
Zurück zum Zitat Krieger JN, Nyberg L Jr, Nickel JC (1999) NIH consensus definition and classification of prostatitis. JAMA 282:236–237CrossRef Krieger JN, Nyberg L Jr, Nickel JC (1999) NIH consensus definition and classification of prostatitis. JAMA 282:236–237CrossRef
17.
Zurück zum Zitat Shoskes DA, Wang H, Polackwich AS et al (2016) Analysis of gut microbiome reveals significant differences between men with chronic prostatitis/chronic pelvic pain syndrome and controls. J Urol 196:435–441CrossRef Shoskes DA, Wang H, Polackwich AS et al (2016) Analysis of gut microbiome reveals significant differences between men with chronic prostatitis/chronic pelvic pain syndrome and controls. J Urol 196:435–441CrossRef
18.
Zurück zum Zitat Karstens L, Asquith M, Davin S et al (2016) Does the urinary microbiome play a role in urgency urinary incontinence and its severity? Front Cell Infect Microbiol 6:78CrossRef Karstens L, Asquith M, Davin S et al (2016) Does the urinary microbiome play a role in urgency urinary incontinence and its severity? Front Cell Infect Microbiol 6:78CrossRef
19.
Zurück zum Zitat Pearce MM, Zilliox MJ, Rosenfeld AB et al (2015) The female urinary microbiome in urgency urinary incontinence. Am J Obstet Gynecol 213:347.e1–347.e11CrossRef Pearce MM, Zilliox MJ, Rosenfeld AB et al (2015) The female urinary microbiome in urgency urinary incontinence. Am J Obstet Gynecol 213:347.e1–347.e11CrossRef
20.
Zurück zum Zitat Brubaker L, Nager CW, Richter HE et al (2014) Urinary bacteria in adult women with urgency urinary incontinence. Int Urogynaecol J 25:1179–1184CrossRef Brubaker L, Nager CW, Richter HE et al (2014) Urinary bacteria in adult women with urgency urinary incontinence. Int Urogynaecol J 25:1179–1184CrossRef
21.
Zurück zum Zitat Pearce MM, Hilt EE, Rosenfeld AB et al (2014) The female urinary microbiome: a comparison of women with and without urgency urinary incontinence. mBio 5:e01283-14CrossRef Pearce MM, Hilt EE, Rosenfeld AB et al (2014) The female urinary microbiome: a comparison of women with and without urgency urinary incontinence. mBio 5:e01283-14CrossRef
22.
Zurück zum Zitat Fouts DE, Pieper R, Szpakowski S et al (2012) Integrated next-generation sequencing of 16S rDNA and metaproteomics differentiate the healthy urine microbiome from asymptomatic bacteriuria in neuropathic bladder associated with spinal cord injury. J Transl Med 10:174CrossRef Fouts DE, Pieper R, Szpakowski S et al (2012) Integrated next-generation sequencing of 16S rDNA and metaproteomics differentiate the healthy urine microbiome from asymptomatic bacteriuria in neuropathic bladder associated with spinal cord injury. J Transl Med 10:174CrossRef
23.
Zurück zum Zitat Mouraviev V, McDonald MW (2018) MP23-06 An utilization of next generation sequencing of urine samples for monitoring of urinary tract infection in patients with neurogenic bladder. J Urol 199:e283 Mouraviev V, McDonald MW (2018) MP23-06 An utilization of next generation sequencing of urine samples for monitoring of urinary tract infection in patients with neurogenic bladder. J Urol 199:e283
24.
Zurück zum Zitat Smelov V, Naber K, Bjerklund Johansen TE (2016) Improved classification of urinary tract infection: future consideration. Eur Urol Suppl 15:71–80CrossRef Smelov V, Naber K, Bjerklund Johansen TE (2016) Improved classification of urinary tract infection: future consideration. Eur Urol Suppl 15:71–80CrossRef
25.
Zurück zum Zitat Hiergeist A, Gessner A (2017) Clinical implications of microbiome in urinary tract diseases. Curr Opin Urol 27:93–98CrossRef Hiergeist A, Gessner A (2017) Clinical implications of microbiome in urinary tract diseases. Curr Opin Urol 27:93–98CrossRef
26.
Zurück zum Zitat Pak TR, Kasarkis A (2015) How Next-Generation Sequencing and multiscale data analysis will transform infection disease management. Clin Infect Dis 61:1695–1702PubMedPubMedCentral Pak TR, Kasarkis A (2015) How Next-Generation Sequencing and multiscale data analysis will transform infection disease management. Clin Infect Dis 61:1695–1702PubMedPubMedCentral
27.
Zurück zum Zitat Smelov V, Naber K, Bjerklund Johansen TE (2016) Letter to the editor: DIAGNOSTIC criteria in urological diseases do not always match with findings by extended culture techniques and metagenomics sequencing of 16S rDNA. Open Microbiol J 10:23–26CrossRef Smelov V, Naber K, Bjerklund Johansen TE (2016) Letter to the editor: DIAGNOSTIC criteria in urological diseases do not always match with findings by extended culture techniques and metagenomics sequencing of 16S rDNA. Open Microbiol J 10:23–26CrossRef
28.
Zurück zum Zitat Davenport M, Mach KE, Shortliffe LMD et al (2017) New and developing diagnostic technologies for urinary tract infection. Nat Rev Urol 14:296–310CrossRef Davenport M, Mach KE, Shortliffe LMD et al (2017) New and developing diagnostic technologies for urinary tract infection. Nat Rev Urol 14:296–310CrossRef
29.
Zurück zum Zitat Onsongo G, Erdmann J, Spears MD et al (2014) Implementation of cloud based next generation sequencing data analysis in a clinical laboratory. BMC Res Notes 7:314CrossRef Onsongo G, Erdmann J, Spears MD et al (2014) Implementation of cloud based next generation sequencing data analysis in a clinical laboratory. BMC Res Notes 7:314CrossRef
30.
Zurück zum Zitat Aziz N, Zhao Q, Bry L et al (2015) College of American Pathologists’ laboratory standards for next-generation sequencing clinical tests. Arch Pathol Lab Med 139:481–493CrossRef Aziz N, Zhao Q, Bry L et al (2015) College of American Pathologists’ laboratory standards for next-generation sequencing clinical tests. Arch Pathol Lab Med 139:481–493CrossRef
Metadaten
Titel
Metagenomics in diagnosis and improved targeted treatment of UTI
verfasst von
Matthew Dixon
Maria Stefil
Michael McDonald
Truls Erik Bjerklund-Johansen
Kurt Naber
Florian Wagenlehner
Vladimir Mouraviev
Publikationsdatum
03.04.2019
Verlag
Springer Berlin Heidelberg
Erschienen in
World Journal of Urology
Print ISSN: 0724-4983
Elektronische ISSN: 1433-8726
DOI
https://doi.org/10.1007/s00345-019-02731-9

Alphablocker schützt vor Miktionsproblemen nach der Biopsie

16.05.2024 alpha-1-Rezeptorantagonisten Nachrichten

Nach einer Prostatabiopsie treten häufig Probleme beim Wasserlassen auf. Ob sich das durch den periinterventionellen Einsatz von Alphablockern verhindern lässt, haben australische Mediziner im Zuge einer Metaanalyse untersucht.

S3-Leitlinie zur unkomplizierten Zystitis: Auf Antibiotika verzichten?

15.05.2024 Harnwegsinfektionen Nachrichten

Welche Antibiotika darf man bei unkomplizierter Zystitis verwenden und wovon sollte man die Finger lassen? Welche pflanzlichen Präparate können helfen? Was taugt der zugelassene Impfstoff? Antworten vom Koordinator der frisch überarbeiteten S3-Leitlinie, Prof. Florian Wagenlehner.

Viel pflanzliche Nahrung, seltener Prostata-Ca.-Progression

12.05.2024 Prostatakarzinom Nachrichten

Ein hoher Anteil pflanzlicher Nahrung trägt möglicherweise dazu bei, das Progressionsrisiko von Männern mit Prostatakarzinomen zu senken. In einer US-Studie war das Risiko bei ausgeprägter pflanzlicher Ernährung in etwa halbiert.

Darf man die Behandlung eines Neonazis ablehnen?

08.05.2024 Gesellschaft Nachrichten

In einer Leseranfrage in der Zeitschrift Journal of the American Academy of Dermatology möchte ein anonymer Dermatologe bzw. eine anonyme Dermatologin wissen, ob er oder sie einen Patienten behandeln muss, der eine rassistische Tätowierung trägt.

Update Urologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.